Related Experiment Video
Updated: May 30, 2026

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
Published on: May 14, 2018
Mutational inactivation of STAG2 causes aneuploidy in human cancer
David A Solomon1, Taeyeon Kim, Laura A Diaz-Martinez
1Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University School of Medicine, Washington, DC 20057, USA.
Abstract:
Most cancer cells are characterized by aneuploidy, an abnormal number of chromosomes. We have identified a clue to the mechanistic origins of aneuploidy through integrative genomic analyses of human tumors. A diverse range of tumor types were found to harbor deletions or inactivating mutations of STAG2, a gene encoding a subunit of the cohesin complex, which regulates the separation of sister chromatids during cell division. Because STAG2 is on the X chromosome, its inactivation requires only a single mutational event. Studying a near-diploid human cell line with a stable karyotype, we found that targeted inactivation of STAG2 led to chromatid cohesion defects and aneuploidy, whereas in two aneuploid human glioblastoma cell lines, targeted correction of the endogenous mutant alleles of STAG2 led to enhanced chromosomal stability. Thus, genetic disruption of cohesin is a cause of aneuploidy in human cancer.
Insights
Cancer cells often have abnormal chromosome numbers (aneuploidy). Researchers found that mutations in the STAG2 gene disrupt chromosome separation, causing aneuploidy in various human tumors.
Area of Science:
- Genomics
- Cancer Biology
- Cell Division
Background:
- Aneuploidy, an abnormal chromosome count, is a hallmark of most human cancers.
- The cohesin complex is crucial for accurate sister chromatid separation during cell division.
Purpose of the Study:
- To investigate the mechanistic origins of aneuploidy in human tumors.
- To determine the role of STAG2 gene mutations in the development of aneuploidy.
Main Methods:
- Integrative genomic analyses of diverse human tumor types.
- Targeted inactivation of the STAG2 gene in a human cell line.
- Targeted correction of STAG2 mutations in glioblastoma cell lines.
Main Results:
- Deletions or inactivating mutations of STAG2 were identified across various tumor types.
- STAG2 inactivation in a normal cell line induced chromatid cohesion defects and aneuploidy.
- Correction of STAG2 mutations in cancer cells enhanced chromosomal stability.
Conclusions:
- Genetic disruption of the cohesin subunit STAG2 is a direct cause of aneuploidy in human cancer.
- STAG2, located on the X chromosome, is susceptible to inactivation, contributing to cancer development.
Related Concept Videos
Nondisjunction
Nondisjunction
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell

